Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1996
10/10/1996WO1996031237A2 Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant
10/10/1996WO1996031234A1 Combination compositions containing benazepril or benazeprilat and valsartan
10/10/1996WO1996031220A1 Cyclodextrin compounds and methods of making and use thereof
10/10/1996WO1996031219A1 Inhibition of c. difficile infections by indigestible oligosaccharides
10/10/1996WO1996031217A1 Inhibiting retroviral replication
10/10/1996WO1996031216A1 A method of preventing colon cancer with vitamin d3 analogues
10/10/1996WO1996031215A1 Use of vitamin d2 or vitamin d4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
10/10/1996WO1996031213A1 Pharmaceutical composition containing proton pump inhibitors
10/10/1996WO1996031212A1 A method for the treatment of macular degeneration
10/10/1996WO1996031211A1 Protective agent for organ or tissue
10/10/1996WO1996031210A1 USE OF IMIDAZO[1,2-a]PYRIDINE-3-ACETAMIDE DERIVATIVES FOR THE THERAPEUTIC TREATMENT OF NEUROPSYCHIATRIC SYNDROMES ASSOCIATED WITH DISFUNCTION OF THE NEURAL CIRCUITS OF THE BASAL GANGLIA
10/10/1996WO1996031209A1 Pharmaceutical agents for the treatment of alzheimer's disease
10/10/1996WO1996031208A2 Use of substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders
10/10/1996WO1996031207A1 Podofilox gel formulation
10/10/1996WO1996031206A2 Flavones and coumarins as agents for the treatment of atherosclerosis
10/10/1996WO1996031205A1 Compositions and process for treating uremic pruritus
10/10/1996WO1996031204A1 Compositions and process for treating hemangioma
10/10/1996WO1996031203A1 Composition and process for prevention and treatment of cutaneous delayed hypersensitivity reactions
10/10/1996WO1996031201A1 Rate-controlled transdermal administration of risperidone
10/10/1996WO1996031197A1 Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
10/10/1996WO1996031195A1 Package holding a procaterol hydrochloride aqueous solution formulation, and a procaterol hydrochloride aqueous solution formulation
10/10/1996WO1996031193A1 Composition and process for prevention and treatment of cutaneous immediate hypersensitivity reactions
10/10/1996WO1996031191A1 Cosmetic compositions for artificial tanning
10/10/1996WO1996031172A1 Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression
10/10/1996WO1996031130A2 Calcium supplements and calcium containing beverages comprising vitamin d
10/10/1996WO1996031129A1 Therapeutic food composition and method to diminish blood sugar fluctuations
10/10/1996WO1996031128A1 Cereal food product high in soluble fiber
10/10/1996WO1996031111A1 Tricyclic compounds useful in the treatment of cell proliferative disorders
10/10/1996WO1996026747A3 Use of amidoamines in ophthalmic compositions
10/10/1996WO1996026718A3 Controlled release tablet
10/10/1996WO1996023771A3 Platelet aggregation inhibitors
10/10/1996WO1996022990A3 Aza and aza (n-oxy) analogs of glycine/nmda receptor antagonists
10/10/1996DE19513662A1 Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption A pharmaceutical combination hormonal contraception
10/10/1996DE19513630A1 Use of AMPA agonists to stimulate prodn. of ciliary neurotrophic factor
10/10/1996CA2420614A1 Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
10/10/1996CA2217695A1 Azole compounds with antimycotic activity for human and veterinary use
10/10/1996CA2217680A1 Tricyclic compounds useful in the treatment of cell proliferative disorders
10/10/1996CA2217651A1 Substituted pyridine derivatives, their preparation and their use as modulators of acetylcholine receptors
10/10/1996CA2217360A1 Package holding a procaterol hydrochloride aqueous solution formulation, and a procaterol hydrochloride aqueous solution formulation
10/10/1996CA2217346A1 Method of production of antigen-specific glycosylation inhibiting factor
10/10/1996CA2217305A1 Cyclodextrin compounds and methods of making and use thereof
10/10/1996CA2217264A1 Calcium supplements and calcium containing beverages comprising vitamin d
10/10/1996CA2217213A1 9-substituted porphycenes
10/10/1996CA2217206A1 Novel heterocyclic compounds
10/10/1996CA2217202A1 Novel heterocyclic compounds
10/10/1996CA2217200A1 Novel method
10/10/1996CA2217198A1 Novel heterocyclic compounds
10/10/1996CA2217197A1 Novel heterocyclic compounds
10/10/1996CA2217194A1 Novel heterocyclic compounds
10/10/1996CA2217164A1 Sugar-modified cytostatics
10/10/1996CA2217130A1 Novel heterocyclic compounds
10/10/1996CA2216934A1 Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
10/10/1996CA2216809A1 Imidazo[1,2-a]pyridine derivatives
10/10/1996CA2216654A1 Inhibitors of farnesyl-protein transferase
10/10/1996CA2216599A1 Mdp derivatives and conjugates having haematopoietic function stimulating activity, and compositions containing same
10/10/1996CA2216562A1 Ascomycins
10/10/1996CA2216363A1 Composition and process for prevention and treatment of cutaneous delayed hypersensitivity reactions
10/10/1996CA2216281A1 A method for the treatment of macular degeneration
10/10/1996CA2216092A1 Expression library immunization
10/10/1996CA2215978A1 Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant
10/10/1996CA2215469A1 5h,10h-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives
10/10/1996CA2215166A1 Benzamides for neurodegenerative disorder treatment
10/10/1996CA2215111A1 Selected soluble esters of hydroxyl-containing indolocarbazoles
10/10/1996CA2214420A1 Rate-controlled transdermal administration of risperidone
10/10/1996CA2214411A1 9-substituted porphycenes
10/10/1996CA2214143A1 Combination compositions containing benazepril or benazeprilat and valsartan
10/09/1996EP0736535A1 Process for the production of dihydroartemisin-hemisuccinate
10/09/1996EP0736534A1 Process for preparing epibatidine
10/09/1996EP0736532A1 Pyrido(3,2-e)pyrazinones with antiasthmatic activity and process for their preparation
10/09/1996EP0736531A1 Alpha-substituted pyridazino quinoline compounds
10/09/1996EP0736530A2 Retinoid-like heterocycles
10/09/1996EP0736527A1 Imadazoline derivative, possible tautomer thereof, process of manufacturing therefor, and vulnerary including such derivative or tautomer
10/09/1996EP0736526A1 Pyrazolidine derivative, radical scavenger, brain-infarction depressant, and brain-edema depressant
10/09/1996EP0736525A1 Benzonitriles and -fluorides as 5-HT agonists and antagonists
10/09/1996EP0736522A1 Ceramide compounds, process for their preparation and their use in cosmetics or dermatology
10/09/1996EP0736302A2 Protease inhibitors, a DNA construct for the expression of a protease and a process for measuring proteases and/or protease inhibitors
10/09/1996EP0736301A1 Pharmaceutical composition containing lysine acetylsalicylate and vitamin E
10/09/1996EP0736300A2 Use in a composition of a pyrimidine derivative substituted in position 6 as an activator and/or stabilizer of cyclooxygenase
10/09/1996EP0736299A1 Process for preparing a liposomal, water-dispersable, solid, dry, therapeutic formulation for oral administration
10/09/1996EP0736256A1 Enantiomerically-enhanced nutritional energy substrates
10/09/1996EP0736094A1 Polycystic kidney disease 1 gene and uses thereof
10/09/1996EP0736093A1 ANTISENSE NUCLEIC ACIDS FOR THE PREVENTION AND TREATMENT OF DISORDERS IN WHICH EXPRESSION OF c-erbB PLAYS A ROLE
10/09/1996EP0736036A1 Kininogen inhibitors
10/09/1996EP0736033A1 Novel therapeutic carbohydrate blends useful for aiding premenstrual syndrome
10/09/1996EP0736032A1 Heterocyclic compounds
10/09/1996EP0736030A1 Tetrahydrofuran antifungals
10/09/1996EP0736029A1 Anticonvulsant pseudofructopyranose sulfamates
10/09/1996EP0736028A1 Indoline derivatives, method of preparation and their use as pharmaceuticals
10/09/1996EP0736026A1 New pyridazino 4',5':3,4]pyrrolo- 2,1-a]isoquinolines and their use for preparing pharmaceutical compositions
10/09/1996EP0736025A1 Dyhydrobenzofuranyl-biphenyl carboxamides having 5ht 1d? antagonistic activity
10/09/1996EP0736024A1 N-heterobicyclyl-piperazinyl or-piperadinyl tricyclic derivatives useful as dopamine receptor ligands
10/09/1996EP0736023A1 Indole, indoline and quinoline derivatives with 5ht 1d? (anti-depressive) activity
10/09/1996EP0736022A1 5-(2-imidazolinylamino)benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agonists
10/09/1996EP0736021A1 Polymorphs of losartan and the process for the preparation of form ii of losartan
10/09/1996EP0736020A1 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
10/09/1996EP0736018A1 4,5-diaryloxazole derivatives
10/09/1996EP0736016A1 Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitor
10/09/1996EP0736015A1 Novel antiviral 2,4-pyrimidinedione derivatives and processes for the preparation thereof
10/09/1996EP0736013A1 N-substituted aryl trifluoromethyl imidazoles
10/09/1996EP0736012A1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations
1 ... 6871 6872 6873 6874 6875 6876 6877 6878 6879 6880 6881 6882 6883 6884 6885 6886 6887 6888 6889 6890 6891 ... 7860